BYSI
Price:
$1.57
Market Cap:
$64.56M
BeyondSpring Inc. is a clinical-stage biopharmaceutical company focused on developing novel cancer treatments. Its flagship product is Plinabulin, a selective immune-modulating and microtubule-binding agent. Plinabulin has successfully advanced through Phase III clinical trials for two distinct applications: the prevention of chemotherapy-induced neutropenia, and the treatment of advanced non-small cell lung cancer. The company is also exploring Plinabulin's efficacy in combination with various immuno-oncology drugs; specifically, alongside nivolumab (a PD-1 antibody) for NSCLC, and with nivolumab and ipilimumab (a CTLA-4 antibody) for small cell lung cancer (SCLC). Furthermore, it is being ...[Read more]
Industry
Biotechnology
IPO Date
2017-03-09
Stock Exchange
NASDAQ
Ticker
BYSI
According to BeyondSpring Inc.’s latest financial reports and current stock price. The company's current ROE is 23.76%. This represents a change of 300.57% compared to the average of 5.93% of the last 4 quarters.
The mean historical ROE of BeyondSpring Inc. over the last ten years is 52.72%. The current 23.76% ROE has changed -54.92% with respect to the historical average. Over the past ten years (40 quarters), BYSI's ROE was at its highest in in the December 2018 quarter at 181.78%. The ROE was at its lowest in in the September 2018 quarter at -255.43%.
Average
52.72%
Median
-22.09%
Minimum
-338.91%
Maximum
706.53%
Discovering the peaks and valleys of BeyondSpring Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 248.47%
Maximum Annual ROE = 706.53%
Minimum Annual Increase = -331.42%
Minimum Annual ROE = -338.91%
| Year | ROE | Change |
|---|---|---|
| 2025 | 24.85% | -26.50% |
| 2024 | 33.81% | -56.90% |
| 2023 | 78.44% | -85.91% |
| 2022 | 556.60% | -331.42% |
| 2021 | -240.51% | 248.47% |
| 2020 | -69.02% | -45.13% |
| 2019 | -125.79% | -117.80% |
| 2018 | 706.53% | -308.47% |
| 2017 | -338.91% | 242.92% |
| 2016 | -98.83% | 10.98% |
The current ROE of BeyondSpring Inc. (BYSI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
45.70%
5-year avg
90.64%
10-year avg
52.72%
BeyondSpring Inc.’s ROE is greater than ALX Oncology Holdings Inc. (-124.06%), greater than MindWalk Holdings Corp. (-63.24%), greater than aTyr Pharma, Inc. (-99.87%), greater than Precision BioSciences, Inc. (-81.24%), greater than Fractyl Health, Inc. Common Stock (-4573.89%), less than Quince Therapeutics, Inc. (1.82%), greater than CAMP4 Therapeutics Corporation (-194.74%), greater than Biomea Fusion, Inc. (-196.72%), greater than Repare Therapeutics Inc. (-57.56%), greater than Unicycive Therapeutics, Inc. (-131.18%),
| Company | ROE | Market cap |
|---|---|---|
| -124.06% | $212.61M | |
| -63.24% | $72.87M | |
| -99.87% | $43.18M | |
| -81.24% | $78.25M | |
| -4573.89% | $61.36M | |
| 1.82% | $5.20M | |
| -194.74% | $89.00M | |
| -196.72% | $69.61M | |
| -57.56% | $114.24M | |
| -131.18% | $155.81M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BeyondSpring Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BeyondSpring Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is BeyondSpring Inc.'s ROE?
How is the ROE calculated for BeyondSpring Inc. (BYSI)?
What is the highest ROE for BeyondSpring Inc. (BYSI)?
What is the 3-year average ROE for BeyondSpring Inc. (BYSI)?
What is the 5-year average ROE for BeyondSpring Inc. (BYSI)?
How does the current ROE for BeyondSpring Inc. (BYSI) compare to its historical average?